Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered...
New treatments will step in to replace blockbuster eye medication EYLEA.
/PRNewswire/ -- A panel of judges has shut the door on an attempt by Bayer (OTCMKTS: BAYZF) and its Monsanto subsidiary to quietly settle a group of lawsuits...
NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Bayer Aktiengesellschaft (“Bayer”...
NEW YORK, Sept. 13, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bayer Aktiengesellschaft (OTC: BAYRY, BAYZF) between May 23, 2016...
Investors with losses of $1,000,000 or more are encouraged to contact the firm
Investors with losses of $1,000,000 or more are encouraged to contact the firm
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bayer Aktiengesellschaft (OTC: BAYRY, BAYZF) between May 23, 2016...
NEW YORK, Aug. 22, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bayer Aktiengesellschaft (OTC: BAYRY, BAYZF) between May 23, 2016...
NEW YORK, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bayer Aktiengesellschaft (OTC: BAYRY, BAYZF) between May 23, 2016...